Smart for Life (SMFL) Competitors $0.0002 0.00 (0.00%) As of 05/20/2025 02:56 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock SMFL vs. AMPE, CALA, CMRA, CLVR, EFTR, ONCSQ, PXMD, ATNFW, LBPSW, and AEHAWShould you be buying Smart for Life stock or one of its competitors? The main competitors of Smart for Life include Ampio Pharmaceuticals (AMPE), Calithera Biosciences (CALA), Comera Life Sciences (CMRA), Clever Leaves (CLVR), eFFECTOR Therapeutics (EFTR), OncoSec Medical (ONCSQ), PaxMedica (PXMD), 180 Life Sciences (ATNFW), 4D pharma (LBPSW), and Aesther Healthcare Acquisition (AEHAW). These companies are all part of the "pharmaceutical products" industry. Smart for Life vs. Ampio Pharmaceuticals Calithera Biosciences Comera Life Sciences Clever Leaves eFFECTOR Therapeutics OncoSec Medical PaxMedica 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Smart for Life (NASDAQ:SMFL) and Ampio Pharmaceuticals (NYSE:AMPE) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, community ranking, institutional ownership, media sentiment and risk. Does the media refer more to SMFL or AMPE? In the previous week, Ampio Pharmaceuticals had 1 more articles in the media than Smart for Life. MarketBeat recorded 1 mentions for Ampio Pharmaceuticals and 0 mentions for Smart for Life. Smart for Life's average media sentiment score of 0.00 equaled Ampio Pharmaceuticals'average media sentiment score. Company Overall Sentiment Smart for Life Neutral Ampio Pharmaceuticals Neutral Do insiders and institutionals have more ownership in SMFL or AMPE? 28.4% of Smart for Life shares are owned by institutional investors. Comparatively, 5.7% of Ampio Pharmaceuticals shares are owned by institutional investors. 31.7% of Smart for Life shares are owned by company insiders. Comparatively, 3.3% of Ampio Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Is SMFL or AMPE more profitable? Company Net Margins Return on Equity Return on Assets Smart for LifeN/A N/A N/A Ampio Pharmaceuticals N/A N/A N/A Does the MarketBeat Community believe in SMFL or AMPE? Smart for Life received 1 more outperform votes than Ampio Pharmaceuticals when rated by MarketBeat users. Likewise, 100.00% of users gave Smart for Life an outperform vote while only 0.00% of users gave Ampio Pharmaceuticals an outperform vote. CompanyUnderperformOutperformSmart for LifeOutperform Votes1100.00% Underperform VotesNo VotesAmpio PharmaceuticalsOutperform VotesNo VotesUnderperform Votes78100.00% Which has more volatility & risk, SMFL or AMPE? Smart for Life has a beta of 1.63, meaning that its stock price is 63% more volatile than the S&P 500. Comparatively, Ampio Pharmaceuticals has a beta of 3.9, meaning that its stock price is 290% more volatile than the S&P 500. Which has better earnings & valuation, SMFL or AMPE? Ampio Pharmaceuticals has lower revenue, but higher earnings than Smart for Life. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSmart for Life$11.11M0.00-$22.68MN/AN/AAmpio PharmaceuticalsN/AN/A-$8.63M-$11.010.00 SummarySmart for Life beats Ampio Pharmaceuticals on 5 of the 8 factors compared between the two stocks. Get Smart for Life News Delivered to You Automatically Sign up to receive the latest news and ratings for SMFL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart SMFL vs. The Competition Export to ExcelMetricSmart for LifeMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$1,000.00$1.16B$5.43B$8.48BDividend YieldN/AN/A5.22%4.11%P/E RatioN/A10.5526.7920.05Price / Sales0.008.44394.72116.44Price / CashN/A10.4038.2534.62Price / Book0.001.466.864.61Net Income-$22.68M-$54.34M$3.22B$248.19M7 Day PerformanceN/A2.72%6.83%2.97%1 Month PerformanceN/A11.88%13.73%16.58%1 Year PerformanceN/A-38.30%18.22%8.16% Smart for Life Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMFLSmart for LifeN/A$0.00flatN/A-100.0%$1,000.00$11.11M0.00110Gap UpHigh Trading VolumeAMPEAmpio PharmaceuticalsN/A$0.00+3.3%N/A-98.7%$4,000.00N/A0.0020Analyst ForecastGap UpCALACalithera BiosciencesN/A$0.00flatN/A-97.0%$3,000.00N/A0.0060Analyst ForecastCMRAComera Life SciencesN/AN/AN/AN/A$3,000.00$1.00M0.002CLVRClever LeavesN/A$0.00flatN/A-100.0%$1,000.00$17.42M0.00560EFTReFFECTOR TherapeuticsN/A$0.00-66.7%N/A-100.0%$1,000.00$3.55M0.0010Upcoming EarningsGap DownONCSQOncoSec MedicalN/AN/AN/AN/A$1,000.00N/A0.0040PXMDPaxMedicaN/A$0.00flatN/A-100.0%$1,000.00N/A0.002ATNFW180 Life SciencesN/A$0.01-3.7%N/A+21.5%$0.00N/A0.007Positive NewsGap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.01+205.4%N/A-89.5%$0.00N/A0.002 Related Companies and Tools Related Companies Ampio Pharmaceuticals Competitors Calithera Biosciences Competitors Comera Life Sciences Competitors Clever Leaves Competitors eFFECTOR Therapeutics Competitors OncoSec Medical Competitors PaxMedica Competitors 180 Life Sciences Competitors 4D pharma Competitors Aesther Healthcare Acquisition Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SMFL) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Smart for Life, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Smart for Life With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.